BAX

Baxter Intl
NYSE

Real-time Quotes | Nasdaq Last Sale

87.21
-0.10
-0.11%
After Hours: 87.21 0 0.00% 16:28 07/02 EDT
OPEN
87.64
PREV CLOSE
87.31
HIGH
87.66
LOW
86.93
VOLUME
2.54M
TURNOVER
--
52 WEEK HIGH
95.19
52 WEEK LOW
69.10
MARKET CAP
44.38B
P/E (TTM)
57.07
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 19 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BAX stock price target is 97.47 with a high estimate of 105.00 and a low estimate of 84.00.

EPS

BAX News

More
Dividend Growth 50: Big Income Growth, Minimal Pandemic Peril
Seeking Alpha - Article · 3d ago
Cramer adds new stocks, recommends buying 12 laggards in his Covid-19 index
"When you look at the biggest winners in the index, they're overwhelmingly tech companies that help facilitate the stay-at-home economy, and a lot of these got hit today," the "Mad Money" host said.
CNBC.com · 4d ago
3 Stocks That Have Grown Earnings Fast
GuruFocus.com · 06/26 17:23
Baxter Publishes 2019 Corporate Responsibility Report, Highlighting Efforts to Make a Meaningful Difference as a Leading Global Corporate Citizen
Business Wire · 06/25 14:00
Here are Wednesday's biggest analyst calls of the day: Alphabet, Dick's, Morgan Stanley & more
Here are the biggest calls on Wall Street on Wednesday
CNBC.com · 06/24 12:55
Oppenheimer Initiates Coverage On Baxter International with Outperform Rating, Announces Price Target of $100
Oppenheimer analyst Suraj Kalia initiates coverage on Baxter International (NYSE:BAX) with a Outperform rating and announces Price Target of $100.
Benzinga · 06/24 10:01
Baxter started at outperform with $100 stock price target at Oppenheimer
marketwatch.com · 06/24 08:12
Dividends Are Down but Not Out. 8 Stocks for the Covid Recession.
Barrons.com · 06/13 01:41

Industry

Medical Equipment, Supplies & Distribution
+0.80%
Healthcare Equipment & Supplies
+0.92%

Hot Stocks

Symbol
Price
%Change

About BAX

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. The Renal business offers a portfolio to meet the needs of patients with end-stage renal disease, or irreversible kidney disease and acute kidney injuries, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision.
More

Webull offers kinds of Baxter International Inc stock information, including NYSE:BAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BAX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BAX stock methods without spending real money on the virtual paper trading platform.